Crossmark

Effects of metformin on transcriptomic and metabolomic profiles in breast cancer survivors enrolled in the randomized placebo-controlled MetBreCS trial

Crossref DOI link: https://doi.org/10.1038/s41598-025-01705-9

Published Online: 2025-05-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Strømland, Pouda Panahandeh

Bertelsen, Bjørn-Erik

Viste, Kristin

Chatziioannou, Anastasia Chrysovalantou

Bellerba, Federica

Robinot, Nivonirina

Trolat, Amarine

Flågeng, Marianne Hauglid

Scalbert, Augustin

Keski-Rahkonen, Pekka

Sears, Dorothy D.

Bonanni, Bernardo

Gandini, Sara

Johansson, Harriet

Mellgren, Gunnar
Funding

Funding for this research was provided by:

University of Bergen
License Information

Text and Data Mining valid from 2025-05-15

Version of Record valid from 2025-05-15
More Information

Article History

Received: 15 July 2024

Accepted: 7 May 2025

First Online: 15 May 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below